Induced Pluripotent Stem Cells Derived CD71＋CD235a＋ Erythroblasts Were Increased by Sirtuin 1 Activator
10.15283/ijsc25040
- Author:
Changyeong KIM
;
Kyung Hwan PARK
;
Soo-Been JEON
;
A-Reum HAN
;
Ji Yoon LEE
;
Young-sup YOON
- Publication Type:BRIEF REPORT
- From:International Journal of Stem Cells
2026;19(1):83-92
- CountryRepublic of Korea
- Language:English
-
Abstract:
Induced pluripotent stem cells (iPSCs) are a promising cell source for regenerative medicine. Clinical applications require a large number of functional red blood cells (RBCs), making it essential to ensure the proliferation of actively dividing, nucleated erythroblasts derived from iPSCs. Small molecules can enhance the efficiency and frequency of iPSC-derived cell differentiation. Sirtuin 1, a key enzyme in multiple biological processes, has been implicated in enhancing iPSC-derived cell differentiation. However, the specific effects of Sirtuin 1 on erythroblast proliferation from iPSCs remain unclear. Here, we developed a protocol to examine the effects of Sirtuin 1 on erythroblasts after endothelial-to-hematopoietic transition (EHT). We found that Sirtuin 1 activation increased the frequency of CD71＋CD235a＋erythroblasts at the early stage after EHT, suggesting a role for Sirtuin 1 in the proliferation of these specified erythroblasts. These findings reveal that Sirtuin 1 activation benefits erythroblast proliferation and could be considered for translational application in large-scale RBC culture.
